Detection and evaluation of p53 intron 2 polymorphism in lung carcinomas in Hong Kong

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 120-124

  Ge, Hong ^a   Lam, Wah K ^b   Lee, Joseph ^c   Wong, Maria P ^b   Fu, Kin H ^c   Yew, Wing W ^c   Lung, Maria L ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BLOOD; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HONG KONG; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BRONCHIECTASIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, P53; HONG KONG; HUMANS; INTRONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SMOKING; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029885181     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<120::AID-IJC9>3.0.CO;2-2     Document Type: Article

References (19)

1. DOCKHORN-DWORNICZAK, B., POREMBA, C., DANTCHEVA, R., STUCKER, A., BROMMELKAMP, E., BLASIUS, S., MELLIN, W., ROESSNER, A., YANDELL, D.W. and BOCKER, W., Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction - based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms. Virchows Arch., 424, 337-342 (1994).
2. FARMER, G., BARGONETTI, J., ZHU, H., FRIEDMAN, P., PRYWES, R. and PRIVES, C., Wild-type p53 activates transcription in vitro. Nature (Lond.), 358, 83-86 (1992).
3. FREBOURG, T., BARBIER, N., YAN, Y.X., GARBER, J.E., DREYFUS, M., FRAUMENI, J., LI, F.P. and FRIEND, S.H., Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Amer J. hum. Genet., 56, 608-615 (1995).
4. GAZDAR, A.F., The molecular and cellular basis of human lung cancer. Anticancer Res., 13, 261-268 (1994).
5. HAHN, M., FISLAGE, R. and PINGOUD, A., Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1 of the human tumor suppressor gene p53 (17p13.1). Hum. Genet., 95, 471-472 (1995).
6. HARTMANN, A., BLASZYK, H., MCGOVERN, R.M., SCHROEDER, J.J., CUNNINGKAM, J., DE VRIES, E.M.G., KOVACH, J.S. and SOMMER, S.S., p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene, 10, 681-688 (1995).
7. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
8. HSU, H.C., HUANG, A.M., LAI, P.L., CHIEN, W.M., PENG, S.Y. and LIN, S.W., Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology, 19, 122-128 (1994).
9. KISHIMOTO, I., MURAKAMI, Y., SHIRAISHI, M., HAYASHI, K. and SEKIYA, T., Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res., 52, 4799-4804 (1992).
10. LAM, K.Y., FU, K.H., WONG, M.P. and WANG, E.P., Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology, 25, 103-105 (1993).
11. LAZAR, V., HAZARD, F., BERTIN, F., JANIN, N., BELLET, D. and BRESSAC, B., Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705 (1993).
12. LUNG, M.L., WONG, M.P., SKAANILD, M.T., FOK, C.L., LAM, W.K. and YEW, W.W..p03 mutations in non-small cell lung carcinomas in Hong Kong. Chest (1996). (In press).
13. MINNA, D., PASS, H., GLATSTEIN, E. and IHDE, D.C., Cancer of the lung. In: V.T. DeVita, S. Heliman and S.A. Rosenberg (eds.). Cancer: principles and practice of oncology, pp. 591-705, Lippincott, Philadelphia (1989).
14. ORITA, M., SUZUKI, Y., SEKIYA, T. and HAYASHI, K., Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics, 5, 874-879 (1989).
15. PLEASANTS, L.M. and HANSEN, M.F., Identification of a polymorphism in intron 2 of the p53 gene. Hum. Genet., 93, 607-608 (1994).
16. SAMBROOK, J., FRITSH, E.F. and MANIATIS, T., Isolation of high-molecular-weight DNA from mammalian cell. In: J. Sambrook (ed.), Molecular cloning: a laboratory manual, pp. 9.16-9.22, CSH Press, Cold Spring Harbor, NY (1989).
17. Soussi, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
18. TAKAHASHI, T., D'AMICO, D., CHIBA, I., BUCHHAGEN, D.L. and MINNA, J.D., Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J. clin. Invest., 86, 363-369 (1990).
19. WESTON, A., CAPORASO, N.E., PERRIN, L.S., SUGIMURA, H., TAMAI, S., KROMIRIS, T.G., TRUMP, B.F., HOOVER, R.N. and HARRIS, C.C., Relationship of H-ras-1, L-nryc, and p53 polymorphisms with lung cancer risk and prognosis. Environ. Hith. Perspect., 98, 61-67 (1992).